Skeletal muscle atrophy is induced by Fbxw beta via atrogene upregulation
- Authors
- Shin, Kyungshin; Ko, Young-Gyu; Jeong, Jaemin; Kwon, Heechung
- Issue Date
- 2월-2017
- Publisher
- WILEY
- Keywords
- atrogenes; dexamethasone; Fbxw7; myogenin; skeletal muscle atrophy
- Citation
- CELL BIOLOGY INTERNATIONAL, v.41, no.2, pp.213 - 220
- Indexed
- SCIE
SCOPUS
- Journal Title
- CELL BIOLOGY INTERNATIONAL
- Volume
- 41
- Number
- 2
- Start Page
- 213
- End Page
- 220
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/84727
- DOI
- 10.1002/cbin.10713
- ISSN
- 1065-6995
- Abstract
- Muscle atrophy decreases skeletal muscle mass and is induced by inherited cachectic symptoms, genetic disorders, and sarcopenia. However, the molecular pathways associated with the onset of muscle atrophy are still unclear. In this study, we evaluated Fbxw7, a gene associated with the development of muscle atrophy in vitro and in vivo. Among the three Fbxw7 isoforms, ectopically overexpressed Fbxw7 induced the expression of myogenin and major atrogene markers (atrogin-1 and MuRF-1) and reduced myoblast differentiation. In addition, endogenous expression of Fbxw7 was also upregulated by dexamethasone, which mimics muscle atrophy in vitro, accompanied by induction of myogenin and atrogene expression in primary myoblasts. Functional analysis of Fbxw7 using short hairpin RNA (shRNA) and a dominant-negative mutant (Fbox) suggested that Fbxw7 regulated muscle atrophy in vitro and in vivo. In particular, Fbox did not reduce the sizes of muscle fibers and did not induce myogenin and atrogene expression in vivo. Therefore, our findings demonstrated, for the first time, that Fbxw7 induced muscle atrophic phenotypes via atrogenes in adult muscle precursor cells and myofibers; this mechanism could be a potential therapeutic target for skeletal muscle atrophy.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.